Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	BeiGene	Astellas Pharma	Shiseido	Takeda Pharmaceutical	Royalty Pharma
Symbol	NASDAQ:BGNE	OTCMKTS:ALPMY	OTCMKTS:SSDOY	OTCMKTS:TKPYY	NASDAQ:RPRX
Price Information
Current Price	$323.67	$15.34	$70.56	$17.20	$41.50
52 Week Range	Hold	Buy	Hold	N/A	Hold
MarketRank™
Overall Score	1.3	1.7	0.9	1.0	1.7
Analysis Score	2.2	0.0	0.0	0.0	2.2
Community Score	2.8	2.7	2.2	2.7	2.7
Dividend Score	0.0	2.5	1.7	0.8	1.7
Ownership Score	0.8	0.0	0.0	0.0	0.8
Earnings & Valuation Score	0.6	3.1	0.6	1.3	1.3
Analyst Ratings
Consensus Recommendation	Hold	Buy	Hold	N/A	Hold
Consensus Price Target	$317.13	N/A	N/A	N/A	$51.88
% Upside from Price Target	-2.02% downside	N/A	N/A	N/A	25.00% upside
Trade Information
Market Cap	$29.68 billion	$28.56 billion	$28.18 billion	$26.87 billion	$25.20 billion
Beta	0.91	0.63	0.33	0.42	N/A
Average Volume	282,822	75,532	18,817	979,605	2,665,974
Sales & Book Value
Annual Revenue	$428.21 million	$11.97 billion	$10.38 billion	$15.99 billion	N/A
Price / Sales	69.31	2.39	2.71	1.68	N/A
Cashflow	N/A	$1.23 per share	$3.38 per share	$2.29 per share	N/A
Price / Cash	N/A	12.47	20.85	7.52	N/A
Book Value	$15.87 per share	$6.28 per share	$11.93 per share	$11.62 per share	N/A
Price / Book	20.40	2.44	5.91	1.48	N/A
Profitability
Net Income	$-948,630,000.00	$1.80 billion	$676.77 million	$1.68 billion	N/A
EPS	($15.80)	$0.96	$1.72	N/A	N/A
Trailing P/E Ratio	N/A	22.23	N/A	12.11	0.00
Forward P/E Ratio	N/A	10.09	75.87	∞	15.43
P/E Growth	N/A	N/A	N/A	N/A	1.94
Net Margins	-569.22%	11.03%	-1.33%	7.84%	N/A
Return on Equity (ROE)	-56.81%	13.24%	0.95%	11.35%	N/A
Return on Assets (ROA)	-39.93%	7.89%	0.40%	5.57%	N/A
Dividend
Annual Payout	N/A	$0.29	$0.27	$0.58	$0.68
Dividend Yield	N/A	1.89%	0.38%	3.37%	1.64%
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	30.21%	15.70%	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	1 Years
Debt
Debt-to-Equity Ratio	0.04%	N/A	0.25%	0.48%	0.59%
Current Ratio	7.69%	1.23%	1.11%	1.42%	10.31%
Quick Ratio	7.64%	0.99%	0.68%	1.12%	10.31%
Ownership Information
Institutional Ownership Percentage	60.65%	0.18%	0.14%	0.19%	40.85%
Insider Ownership Percentage	9.00%	N/A	N/A	N/A	2.50%
Miscellaneous
Employees	5,400	15,883	39,035	N/A	N/A
Shares Outstanding	91.70 million	1.86 billion	399.39 million	1.56 billion	607.11 million
Next Earnings Date	8/5/2021 (Estimated)	8/3/2021 (Estimated)	8/5/2021 (Estimated)	N/A	8/11/2021 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	Royalty Pharma (NASDAQ:RPRX) Announces Quarterly Earnings Results americanbankingnews.com - May 12 at 2:12 PM
	Would I Choose Royalty Pharma plc (NASDAQ:RPRX) Stock at Any Point in Time? stocksregister.com - May 12 at 10:17 AM
	Royalty Pharma: Q1 Earnings Snapshot chron.com - May 11 at 8:27 AM
	Royalty Pharma Reports First Quarter 2021 Results finance.yahoo.com - May 11 at 8:27 AM
	Should You Buy Royalty Pharma (RPRX) Ahead of Earnings? msn.com - May 10 at 12:25 PM
	Why Is GlaxoSmithKline Selling Its Income Stream to Royalty Pharma? msn.com - May 9 at 3:19 PM
	Royalty Pharma plc (RPRX): Price Now Near $41.94; Daily Chart Shows Downtrend on 100 Day Basis etfdailynews.com - May 8 at 1:47 AM
	Royalty Pharma to Present at Upcoming Investor Conferences benzinga.com - May 7 at 9:14 AM
	Is Royalty Pharma plc's (NASDAQ:RPRX) 17% ROE Strong Compared To Its Industry? nasdaq.com - May 6 at 2:38 PM
	Royalty Pharma: A Potentially Long-Term Dividend Investment seekingalpha.com - May 5 at 10:59 AM
	Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021 finance.yahoo.com - April 21 at 7:00 PM
	MSCI Announces Strategic Alliance With Royalty Pharma to Launch Life Sciences Indexes uk.finance.yahoo.com - April 21 at 1:59 PM
	Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes finance.yahoo.com - April 21 at 8:59 AM
	Royalty Pharma Plc (RPRX) investing.com - April 18 at 10:37 PM
	Royalty Pharma Plc (RPRX) EVP, Investments & GC George W. Lloyd Sold $2.9 million of Shares uk.finance.yahoo.com - April 16 at 11:05 PM
	Royalty Pharma Declares Second-Quarter 2021 Dividend finance.yahoo.com - April 15 at 9:42 AM
	Insider Sells Royalty Pharma's Shares benzinga.com - April 14 at 2:33 PM
	Royalty Pharma Shows Promise realmoney.thestreet.com - April 9 at 1:34 PM
	Royalty Pharma Acquires Royalty Interest in Cabozantinib From GSK finance.yahoo.com - April 1 at 10:23 AM
	Royalty Pharma Appoints Henry A. Fernandez as Lead Independent Director finance.yahoo.com - March 30 at 8:13 AM
	Is Royalty Pharma a Biotech Stock Worth Buying? stocknews.com - March 26 at 12:39 PM
	SYF vs. RPRX: Which Stock Should Value Investors Buy Now? msn.com - March 25 at 3:51 PM
	Royalty Pharma Plc (RPRX) EVP, Investments & GC George W. Lloyd Sold $2.5 million of Shares finance.yahoo.com - March 24 at 7:51 PM
	Royalty Pharma Plc (RPRX) EVP & CFO Terrance P. Coyne Sold $4.5 million of Shares finance.yahoo.com - March 6 at 1:13 AM
	Relative Strength Alert For Royalty Pharma nasdaq.com - March 4 at 7:52 PM

Date	Company	Brokerage	Action
5/17/2021	BeiGene	Morgan Stanley	Lower Price Target
3/16/2021	BeiGene	HSBC	Boost Price Target
3/8/2021	BeiGene	China Renaissance Securities	Initiated Coverage
3/1/2021	BeiGene	CLSA	Downgrade
2/25/2021	BeiGene	Cowen	Boost Price Target
1/12/2021	BeiGene	Piper Sandler	Boost Price Target
12/8/2020	BeiGene	LADENBURG THALM/SH SH	Upgrade
11/19/2020	BeiGene	SVB Leerink	Boost Price Target
11/6/2020	BeiGene	Maxim Group	Downgrade
5/26/2020	Astellas Pharma	The Goldman Sachs Group	Upgrade
9/24/2019	Astellas Pharma	Jefferies Financial Group	Initiated Coverage
11/5/2018	Astellas Pharma	JPMorgan Chase & Co.	Downgrade
9/13/2018	Astellas Pharma	Deutsche Bank Aktiengesellschaft	Downgrade
11/11/2020	Shiseido	Daiwa Capital Markets	Upgrade
11/9/2020	Royalty Pharma	UBS Group	Upgrade
7/14/2020	Royalty Pharma	Evercore ISI	Initiated Coverage
7/13/2020	Royalty Pharma	Bank of America	Initiated Coverage
7/13/2020	Royalty Pharma	Citigroup	Initiated Coverage
7/13/2020	Royalty Pharma	SunTrust Banks	Initiated Coverage

(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources